Increase in Oral Streptococcal Endocarditis Among Moderate-Risk Patients
Oral streptococcal IEs increased in the moderate-risk group of patients after the AP guideline change. Exploring the potential necessity for expanding AP indications to certain patient groups with congenital valve anomalies may be warranted.
Authors
- Jana Epprecht (ORCID: https://orcid.org/0000-0003-3277-7044)
- Thierry Carrel (ORCID: https://orcid.org/0000-0002-7881-6822)
- Mathias Van Hemelrijck (ORCID: https://orcid.org/0000-0002-0191-757X)
- Matthias Greutmann (ORCID: https://orcid.org/0000-0002-8692-6108)
- Barbara Hasse (ORCID: https://orcid.org/0000-0001-7196-3734)
- Bernd Stadlinger (ORCID: https://orcid.org/0000-0001-5044-7052)
- Mutlu Özcan (ORCID: https://orcid.org/0000-0002-9623-6098)
- Maria Padrutt
- Lilly Ilcheva
- Bruno Ledergerber (ORCID: https://orcid.org/0000-0002-6881-4401)
- Michelle Frank (ORCID: https://orcid.org/0009-0001-9459-6022)
Institutions
- University of Zurich (CH)
- University Hospital of Basel (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101266
- Citations
- 4
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Universität Zürich